Early detection of colorectal neoplasia: application of a blood-based serological protein test on subjects undergoing population-based screening.

The performance of the biomarker signature in this FIT-positive screening population did not reflect the positive performance of biomarker signatures seen in symptomatic populations. Additional biomarkers are needed if the serological biomarkers are to be used as a frontline screening test.